Adverum Biotechnologies, Inc. (LON:0HA3)
2.203
+0.042 (1.93%)
At close: Jul 1, 2025
Adverum Biotechnologies Revenue
Adverum Biotechnologies had revenue of $1.00M USD in the twelve months ending March 31, 2025. In the year 2024, Adverum Biotechnologies had annual revenue of $1.00M, down -72.22%.
Revenue
$1.00M
Revenue Growth
-72.22%
P/S Ratio
45.06
Revenue / Employee
$6.45K
Employees
155
Market Cap
34.88M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
Shell | 217.54B |
HSBC Holdings | 44.89B |
Unilever | 50.25B |
Rolls-Royce Holdings | 18.91B |
British American Tobacco p.l.c. | 25.87B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
Adverum Biotechnologies News
- 4 weeks ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Adverum Biotechnologies GAAP EPS of -$2.25 misses by $0.31 - Seeking Alpha
- 7 weeks ago - Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewsWire
- 7 weeks ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire
- 2 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - GlobeNewsWire
- 2 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire
- 2 months ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM - Accesswire